Common Property Trust has filed an amendment to its Schedule 13D, revealing its current beneficial ownership stake in NRC Health. The filing indicates that Common Property Trust now holds 40.6% of NRC Health's common stock, which translates to 8,609,601 shares. This update is significant as it reflects a change in the total number of outstanding shares of NRC Health, which has implications for both the company and its investors.
Background
Common Property Trust, incorporated in Delaware, is a company that operates in the real estate sector. It has been actively involved in updating its ownership stakes in NRC Health, a company that specializes in commercial physical and biological research. The recent filing is part of a series of updates, with the last amendment prior to this one submitted on June 12, 2026.
What the Filing Says
The recent filing, dated November 6, 2026, states, "This Amendment No. 5 is being filed to reflect a change in the beneficial ownership of the Reporting Persons as a result of a decrease in the number of outstanding shares of the Issuer's Common Stock." This indicates that the changes in ownership percentages are not due to new acquisitions but rather due to changes in the overall share count.
Impact
This update may affect various stakeholders, including other shareholders and potential investors in NRC Health. The filing also highlights the involvement of other entities such as Amandla LLC and several trusts managed by Patrick E. Beans, who collectively hold significant portions of NRC Health's stock. With Common Property Trust's substantial stake, it may influence decisions at NRC Health, particularly in strategic planning and governance.
What's Next
The filing does not say what happens next. However, the ongoing monitoring of share ownership and any potential future filings may provide further insights into the strategic direction of Common Property Trust and its relationship with NRC Health.
Read Next
Qualys CEO Thakar Acquires 48,028 Shares in Stock Deal
Qualys Chief Legal Officer Acquires 15,241 Shares of Stock
Baker Bros. Advisors Boosts Stake in Madrigal Pharmaceuticals
Machek Howard Reports Significant Stock Transactions
Net Power's Horstman Amends Stock Options in SEC Filing
Coastlands Capital LP Discloses 17.5% Stake in Bolt Biotherapeutics






